Integrated BioTherapeutics
IBT Bioservices is a contract research organization dedicated to pioneering advancements in biomedical research. They offer comprehensive services spanning preclinical and clinical research, including reagents, assay development, animal models, biosafety level laboratories, and GxP, GLP, and GCLP testing. Their mission is to support pharmaceutical, biotech, academic, and government clients in developing safe and effective treatments, with a focus on innovation, collaboration, and impactful contributions to healthcare.
Industries
Nr. of Employees
small (1-50)
Integrated BioTherapeutics
Products
Recombinant proteins
Purified recombinant viral and bacterial proteins produced in expression systems and processed using chromatographic purification for research and assay use.
Pseudotyped viral particles
Pseudovirus reagents representing diverse viral glycoproteins and strains for neutralization assays, variant testing and assay development.
Primary antibodies
Catalog of monoclonal and polyclonal primary antibodies for research applications including western blot, ELISA, immunoassays and immunohistochemistry.
ELISA kits and serology reagents
Pre-formulated ELISA kits and reagents for detection of human and pathogen-specific antibodies and antigens to support serology and biomarker workflows.
Virus-like particles and specialized cell lines
Non-replicating virus-like particles and specialized cell lines for assay controls, antigen presentation and assay workflows.
Recombinant proteins
Purified recombinant viral and bacterial proteins produced in expression systems and processed using chromatographic purification for research and assay use.
Pseudotyped viral particles
Pseudovirus reagents representing diverse viral glycoproteins and strains for neutralization assays, variant testing and assay development.
Primary antibodies
Catalog of monoclonal and polyclonal primary antibodies for research applications including western blot, ELISA, immunoassays and immunohistochemistry.
ELISA kits and serology reagents
Pre-formulated ELISA kits and reagents for detection of human and pathogen-specific antibodies and antigens to support serology and biomarker workflows.
Virus-like particles and specialized cell lines
Non-replicating virus-like particles and specialized cell lines for assay controls, antigen presentation and assay workflows.
Services
Cell-based antiviral and bacterial testing covering CPE, HAI, microneutralization, PRNT, pseudovirus neutralization, yield-reduction assays, ELISA, multiplex biomarker assays, qPCR, western blot, and viability/cytotoxicity testing.
Rodent and non-human primate infection and efficacy models, immunogenicity studies, PK/PD and biodistribution studies, custom animal model development, dietary and oncology models, and vivarium rental.
Custom recombinant protein expression, purification and bespoke monoclonal and polyclonal antibody generation to support assay development and preclinical studies.
GxP/GLP/GCLP-compliant analytical method development, qualification and validation; GMP release testing and stability program management; regulated clinical sample handling and chain-of-custody.
Designated project contacts, secure sample tracking, centralized program coordination, and client-facing reporting to support integrated development programs.
Technical and planning support for grant and contract submissions, including study design input, budget and timeline estimation, letters of support, and risk mitigation strategies.
Cell-based antiviral and bacterial testing covering CPE, HAI, microneutralization, PRNT, pseudovirus neutralization, yield-reduction assays, ELISA, multiplex biomarker assays, qPCR, western blot, and viability/cytotoxicity testing.
Rodent and non-human primate infection and efficacy models, immunogenicity studies, PK/PD and biodistribution studies, custom animal model development, dietary and oncology models, and vivarium rental.
Custom recombinant protein expression, purification and bespoke monoclonal and polyclonal antibody generation to support assay development and preclinical studies.
GxP/GLP/GCLP-compliant analytical method development, qualification and validation; GMP release testing and stability program management; regulated clinical sample handling and chain-of-custody.
Designated project contacts, secure sample tracking, centralized program coordination, and client-facing reporting to support integrated development programs.
Technical and planning support for grant and contract submissions, including study design input, budget and timeline estimation, letters of support, and risk mitigation strategies.
Expertise Areas
- Preclinical contract research services
- In vitro assay development and validation
- Animal model development and execution
- Biologics and reagent manufacturing
Key Technologies
- Multiplex bead-based immunoassays
- Enzyme-linked immunosorbent assay (ELISA)
- qPCR and molecular detection assays
- Pseudotyped virus production
News & Updates
Attend the ASM Microbe 2025 conference in Los Angeles from June 19-23, 2025.
A promising new therapeutic is being developed to address the urgent need for effective treatments for Marburg virus disease.
IBT Bioservices rebranded from Integrated Biotherapeutics, emphasizing its commitment to contract research services.
Discussion on the development of a multi-component toxoid vaccine for S. aureus and regulatory challenges.
Progress in developing vaccines against S. aureus.
Attend the ASM Microbe 2025 conference in Los Angeles from June 19-23, 2025.
A promising new therapeutic is being developed to address the urgent need for effective treatments for Marburg virus disease.
IBT Bioservices rebranded from Integrated Biotherapeutics, emphasizing its commitment to contract research services.
Discussion on the development of a multi-component toxoid vaccine for S. aureus and regulatory challenges.
Progress in developing vaccines against S. aureus.